Form 8.3 - AON PLC AMENDMENT

Form 8.3 - AON PLC AMENDMENT

BARCLAYS PLC

 

Ap19

FORM 8.3 Amendment to Sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 09 July 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)

(1)

Relevant securities

 

 

 

 

240,135

0.10%

1,497,519

0.65%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

529,637

0.23%

29,700

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

2,600

0.00%

4,500

0.00%

 

 

 

 

TOTAL:

 

 

 

 

772,372

0.33%

1,531,719

0.66%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit

Purchase

1

194.1400 USD

Purchase

1

194.1600 USD

Purchase

1

194.0800 USD

Purchase

1

194.3200 USD

Purchase

1

194.4100 USD

Purchase

1

194.2800 USD

Purchase

2

195.4500 USD

Purchase

4

194.2450 USD

Purchase

5

194.5220 USD

Purchase

8

194.4087 USD

Purchase

16

194.4700 USD

Purchase

32

193.6600 USD

Purchase

43

194.8193 USD

Purchase

88

193.8000 USD

Purchase

99

194.5600 USD

Purchase

100

193.7500 USD

Purchase

100

194.2200 USD

Purchase

200

194.1150 USD

Purchase

255

193.9943 USD

Purchase

258

193.4633 USD

Purchase

295

193.7294 USD

Purchase

327

193.7671 USD

Purchase

515

193.7694 USD

Purchase

551

194.5382 USD

Purchase

689

194.4795 USD

Purchase

800

194.1887 USD

Purchase

951

194.4968 USD

Purchase

1,590

195.0553 USD

Purchase

2,634

194.4560 USD

Purchase

2,666

195.4900 USD

Purchase

5,318

194.0241 USD

Purchase

10,171

194.4600 USD

Purchase

12,953

194.6050 USD

Purchase

13,278

193.7361 USD

Purchase

21,538

193.9341 USD

Purchase

26,085

193.9847 USD

Purchase

28,756

194.0146 USD

Sale

6

193.2400 USD

Sale

32

193.6600 USD

Sale

35

195.4900 USD

Sale

40

194.2013 USD

Sale

41

193.7500 USD

Sale

43

194.8193 USD

Sale

100

193.6950 USD

Sale

100

192.7600 USD

Sale

100

194.6600 USD

Sale

100

194.6100 USD

Sale

102

193.8715 USD

Sale

113

193.7788 USD

Sale

130

193.8523 USD

Sale

165

193.9169 USD

Sale

171

194.9200 USD

Sale

208

194.3379 USD

Sale

213

194.1616 USD

Sale

300

193.8383 USD

Sale

314

193.8259 USD

Sale

323

193.5803 USD

Sale

375

193.6046 USD

Sale

400

194.2262 USD

Sale

401

194.4100 USD

Sale

500

194.2830 USD

Sale

557

194.1944 USD

Sale

600

194.5175 USD

Sale

688

193.4892 USD

Sale

791

193.9360 USD

Sale

793

194.0079 USD

Sale

1,030

193.7694 USD

Sale

1,051

195.3606 USD

Sale

1,100

194.4581 USD

Sale

1,400

193.6971 USD

Sale

1,770

194.1176 USD

Sale

1,800

193.6438 USD

Sale

1,888

194.5239 USD

Sale

2,170

194.4600 USD

Sale

2,700

194.4717 USD

Sale

3,466

194.6461 USD

Sale

3,691

193.7762 USD

Sale

5,040

193.8515 USD

Sale

6,613

193.7078 USD

Sale

6,891

195.0368 USD

Sale

8,553

194.4611 USD

Sale

9,732

193.9936 USD

Sale

10,200

194.2107 USD

Sale

12,624

193.9441 USD

Sale

16,849

194.1301 USD

Sale

24,111

193.9124 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 13 Jul 2020
Contact name: Large Holdings Regulatory Operations
Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates

Call Options

Purchased

1,100

260.0000

American

Jul 17, 2020

Call Options

Purchased

1,500

240.0000

American

Jul 17, 2020

Call Options

Written

-4,500

220.0000

American

Jul 17, 2020

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

UK 100

Latest directors dealings